Laura Ingram, National Institute Of Allergy And Infectious Diseases, Chloroquine discussed on On The Media

On The Media
|

Automatic TRANSCRIPT

And I say it. What do you say to get? What do you have to lose on Saturday? President trump again touted the use of hydroxy chloroquine an anti-malaria drug as a potential treatment for covert nineteen the USC announced has stockpiled. Twenty nine million doses. Though the basis for using the drug to treat the disease is entirely anecdotal. Some doctors are already using it in hospitals around the country. Some report that it might be useful in the early stages of covert nineteen. But we really don't know. And what do we have to lose? There are side effects. Experts warn and it is potentially fatal for patients with heart problems or who are on certain antidepressants. And then there's the side effect of a shortage for people who are actually prescribed drugs clerk in four illnesses like lupus and rheumatoid arthritis yet. We have to be careful Laura that we don't assume something works based on an anecdotal report. That's not controlled and I refers specifically to hydroxy chloroquine. Dr Anthony FAUCI Director of the National Institute of Allergy and Infectious Diseases has been urging caution in White House briefings and in media interviews such as this one with Fox's Laura Ingram. There's a lot of buzz out there on the Internet on the social media about that. Oh there are many eccentric way. Well those studies. Some of them were not control. So why the intense media interest in hydroxy chloroquine even before the president's started talking it up reporting this week for the Guardian Julia. Carrie Wong traced the not so winding path from Fox News. The trump's ears. It's become kind of a mean within the news cycle and.

Coming up next